Argentinian Pharma Elea Laboratories Launches POC Clinical Trial Investigating Ivermectin in Hospitalized COVID-19 Patients

Argentinian Pharma Elea Laboratories Launches POC Clinical Trial Investigating Ivermectin in Hospitalized COVID-19 Patients

Argentina’s Laboratorio Elea Phoenix S.A. (Elea Laboratories) has initiated a proof-of-concept clinical trial with 45 patients to investigate the efficacy of ivermectin as a treatment for patients infected with SARS-CoV-2. The South American pharmaceutical company based its decision on the important Monash University lab study plus the fact that ivermectin has been widely in use for decades. Given the severity of the pandemic Elea Laboratories considers the move rational and a solid opportunity to investigate the potential given the ongoing risks associated with the COVID-19 pandemic.

TrialSite News offers a brief breakdown of this study and situation for the TrialSIte Network.

Who is Elea Laboratories?

Based in Buenos Aires, Argentina, Elea Laboratories is a biotechnology company that both invests ongoing in an internal research and development operation while also specializing in partnering with international biopharmaceutical companies to in-license promising products for development and commercialization in South America. For the latter international partnerships, the company maintains significant marketing, sales and distribution networks representing one o...

Note:  If you need assistance with your subscription or would like to discuss a corporate subscription for more than 10 employees please contact us or use the chat (bottom right).

Personal
$5 / Month
Individuals at home that are reading our content for personal health care or other non-professional reasons.
Like a Starbucks a month
Personal - Single Payment
$50 for 1 Year
Individuals - reading for personal reasons who prefer to pay for one year in advance with no recurring billing.
18% discount to monthly
Professional
$12 / Month
Professionals from the healthcare industry who are subscribing on behalf of their company for work reasons.
Way better than coffee